Updated Meta-Analysis of Pelvic Insufficiency Fractures Post-Radiation in Pelvic Cancer

Overview

This updated meta-analysis evaluated pelvic insufficiency fracture (PIF) rates in 11,272 women treated with pelvic radiation therapy (RT) for pelvic cancers. It provides a comprehensive incidence estimate, detailed subgroup analyses by RT technique and dose, and highlights risk factors such as low bone mineral density and menopausal status.

Background

Pelvic insufficiency fractures are non-traumatic fractures resulting from radiation-induced bone damage, commonly complicating pelvic cancer radiotherapy. These fractures cause persistent pain, limited mobility, and increased mortality risk, imposing significant patient and societal burdens. Previous meta-analyses reported a PIF rate of approximately 14%, but recent advances in RT techniques and emerging risk factor data necessitate an updated comprehensive analysis. This study aims to clarify current PIF incidence and associated factors in the context of modern RT modalities.

Data Highlights

The meta-analysis included 11,272 female patients with pelvic cancers treated with curative pelvic RT. Prior foundational data reported a 14% PIF incidence (95% CI, 10%−18%) based on 3,929 patients from 21 studies. Recent cohort studies cited higher rates, such as 28% and 32%, suggesting an increase or variability with newer RT techniques. Subgroup analyses considered RT modalities including conventional RT, intensity-modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and carbon-ion RT (C-ion RT). Risk factors like low BMI, osteoporosis, and menopausal status were also evaluated for their association with PIF occurrence.

Key Findings

• The overall incidence of pelvic insufficiency fractures after pelvic RT remains significant, with rates reported up to 32% in recent studies, higher than the previously established 14%.
• High-risk fracture locations include the sacroiliac joint and sacral body.
• Advanced RT techniques such as IMRT and VMAT may reduce PIF incidence compared to conventional RT, though data are still emerging.
• Low bone mineral density, osteoporosis, low BMI, and menopausal status are important risk factors associated with increased PIF risk.
• Extended survival of pelvic cancer patients increases the clinical importance of monitoring and preventing PIF to preserve quality of life.
• Heterogeneity among studies is high, necessitating random-effects modeling and careful interpretation of pooled results.

Clinical Implications

Clinicians should be vigilant for pelvic insufficiency fractures in women receiving pelvic RT, especially those with known risk factors such as osteoporosis or low BMI. Utilization of advanced RT techniques like IMRT may mitigate fracture risk. Early detection through appropriate imaging and preventive strategies to maintain bone health are critical to improving patient outcomes and quality of life post-radiotherapy.

Conclusion

Pelvic insufficiency fractures remain a common and serious complication following pelvic radiation therapy in women with pelvic cancers. Updated evidence underscores the need for tailored RT approaches and proactive management of bone health to reduce fracture incidence and associated morbidity.

References

1. Lucas Gomes Sapienza et al. 2019 -- Meta-analysis of PIF incidence after pelvic RT
2. Yuhei Miyasaka et al. -- Recent cohort study on PIF rates
3. Antje Wark et al. -- Impact of RT techniques on PIF incidence